<DOC>
	<DOCNO>NCT00271154</DOCNO>
	<brief_summary>Heart failure progressive disease decrease pump action heart . This may cause backup fluid heart may result heart beat change . When change heart beat sometimes implantable heart device use control rate rhythm heart beat . The purpose REVERSE clinical trial determine whether pace leave right ventricle use Cardiac Resynchronization Therapy ( CRT ) help slow progression heart failure people mild previous symptom poor heart pump function . This kind therapy previously show reduce symptom improve exercise capacity people advance form heart failure .</brief_summary>
	<brief_title>REsynchronization reVErses Remodeling Systolic Left vEntricular Dysfunction ( REVERSE )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<criteria>Subjects previously symptomatic heart failure current symptom ( New York Heart Association ( NYHA ) Class I , Stage C ) subject mild heart failure sometimes interfere daily activity ( NYHA Class II ) Subjects QRS 120 m ( The QRS interval measurement electrical signal involve heart beat travels/conducts ventricle . A wide QRS ( 120 m ) suggest conduction problem ( block ) ventricle ) . Subjects leave ventricular ejection fraction less equal 40 % . ( The left ventricular ejection fraction ( LVEF ) measurement well leave ventricle pump blood rest body . The high LVEF blood ventricle pump . ) Subjects leave ventricular end diastolic dimension ( LVEDD ) great equal 55 . ( The left ventricular end diastolic dimension ( LVEDD ) measurement heart size take echocardiogram one indication health leave ventricle . ) Subjects pacemaker dependent ( heart would beat without help implant device pace ) . Subjects heart failure severely limits daily activity ( NYHA Class III ) subject severe heart failure symptom rest ( NYHA Class IV ) . Subjects hospitalize due heart failure within past 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Implantable Cardioverter Defibrillator</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
</DOC>